BERC-Luso is a project of Biomedical Ethics and Regulatory Capacity Building for Portuguese Speaking African Countries, approved and financed by EDCTP2 (The European & Developing Countries Clinical Trials Partnership), with the support of the European Union (EU) and co-financed by the Calouste Gulbenkian Foundation (FCG). It engages 5 sub-Saharan African countries – Angola, Guinea Bissau, Mozambique, São Tomé e Príncipe and Cape-Verde –, working with their NECs and NRAs, in a partnership with Portuguese institutions experts in the field of ethical and regulatory revision - the Portuguese UNESCO Chair in Bioethics (Institute of Bioethics, Portuguese Catholic University), the National Authority of Medicines and Health Products (INFARMED, I.P.), the National Ethics Committee for Clinical Research (CEIC), and the Portuguese Pharmaceutical Society (Competent Authority for Pharmacists);
WEBINAR CEIC
On June 17th, another webinar dedicated to the analysis of cases took place, presented by Professor Maria Alexandra Ribeiro, who presented a case of a prospective, randomized (1:1) open and multicenter clinical trial phase IIIb/IV to assess the efficacy and safety of the drug compared to clinical practice.
More Info
BERC-Luso participates in the Forum of Regulators from Lusophone Countries
BERC-Luso BERC-Luso in the 11th EDCTP Forum, Paris
BERC-Luso present in the 81st FIP World Congress of Pharmacy and Pharmaceutical Sciences, Brisbane, Australia
Audience of BERC-Luso Coordination with São Tomé and Príncipe Ambassador
October 2019
79th FIP World Congress of Pharmacy and Pharmaceutical Sciences
September 22-26, 2019, Abu Dhabi, United Arab Emirates
Audience of BERC-Luso Coordination Team with São Tomé and Príncipe Ambassador